Table 1 Study cohorts: number of samples and clinical characteristics

Number

27

21

Women (percentage)

16 (59 %)

11 (52 %)

Age in years^a

36 (28–43)

33 (27–48)

Disease duration^a

1.0 year (36 days–6.9 years)

n.a.

EDSS^a

2.5 (2, 3)

n.a.

Albumin quotient (Q _alb)^a

5.4 (4.1–6.8])

4.6 (3.2–7.6)

CSF cell count/μl^a

13 (3.8–20.2)

2 (1–2.3)